These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30149126)

  • 41. Although tapentadol and oxycodone both increase colonic volume, tapentadol treatment resulted in softer stools and less constipation: a mechanistic study in healthy volunteers.
    Mark EB; Frøkjær JB; Hansen TM; Nedergaard RB; Drewes AM
    Scand J Pain; 2021 Apr; 21(2):406-414. PubMed ID: 33606931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans.
    Jeong ID; Camilleri M; Shin A; Iturrino J; Boldingh A; Busciglio I; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Aliment Pharmacol Ther; 2012 May; 35(9):1088-96. PubMed ID: 22348605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of tegaserod on gut transit in male and female subjects.
    Degen L; Petrig C; Studer D; Schroller S; Beglinger C
    Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term oxycodone treatment does not affect electrogenic ion transport in isolated mucosa from the human rectosigmoid colon.
    Nilsson M; Brock C; Poulsen JL; Bindslev N; Hansen MB; Louring Christrup L; Drewes AM
    Scand J Gastroenterol; 2016; 51(5):538-47. PubMed ID: 26610166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Measurement of colon transit time useful in the evaluation of functional constipation].
    Mollen RM; Claassen AT; Kuijpers JH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(7):357-61. PubMed ID: 9562742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and pathophysiology of functional constipation among women in Catalonia, Spain.
    Ribas Y; Saldaña E; Martí-Ragué J; Clavé P
    Dis Colon Rectum; 2011 Dec; 54(12):1560-9. PubMed ID: 22067186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of blinding and expectations in opioid-induced constipation: evidence from a randomized controlled trial.
    Sieg M; Mark EB; Drewes AM; Vase L
    Scand J Pain; 2022 Apr; 22(2):410-416. PubMed ID: 34710314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Classification and treatment of constipation].
    Sung IK
    Korean J Gastroenterol; 2008 Jan; 51(1):4-10. PubMed ID: 18349556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurotrophin-3 improves functional constipation.
    Parkman HP; Rao SS; Reynolds JC; Schiller LR; Wald A; Miner PB; Lembo AJ; Gordon JM; Drossman DA; Waltzman L; Stambler N; Cedarbaum JM;
    Am J Gastroenterol; 2003 Jun; 98(6):1338-47. PubMed ID: 12818279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factor analysis identifies subgroups of constipation.
    Dinning PG; Jones M; Hunt L; Fuentealba SE; Kalanter J; King DW; Lubowski DZ; Talley NJ; Cook IJ
    World J Gastroenterol; 2011 Mar; 17(11):1468-74. PubMed ID: 21472106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subtypes of constipation: sorting out the confusion.
    Prather CM
    Rev Gastroenterol Disord; 2004; 4 Suppl 2():S11-6. PubMed ID: 15184810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic idiopathic constipation: more than a simple colonic transit disorder.
    Shahid S; Ramzan Z; Maurer AH; Parkman HP; Fisher RS
    J Clin Gastroenterol; 2012 Feb; 46(2):150-4. PubMed ID: 22011587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of functional constipation categorized by colonic transit time and pelvic floor electromyography.
    Xiong GY; Zhao ZQ
    Chin J Dig Dis; 2004; 5(4):156-9. PubMed ID: 15612884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sacral Nerve Stimulation Fails to Offer Long-term Benefit in Patients With Slow-Transit Constipation.
    Patton V; Stewart P; Lubowski DZ; Cook IJ; Dinning PG
    Dis Colon Rectum; 2016 Sep; 59(9):878-85. PubMed ID: 27505117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measuring colonic transit time in chronic idiophatic constipation.
    Husni-Hag-Ali R; Gómez Rodríguez BJ; Mendoza Olivares FJ; García Montes JM; Sáchez-Gey Venegas S; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2003 Mar; 95(3):186-90, 181-5. PubMed ID: 12760708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation.
    Malagelada C; Nieto A; Mendez S; Accarino A; Santos J; Malagelada JR; Azpiroz F
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1457-1462. PubMed ID: 28090679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.
    Every-Palmer S; Ellis PM; Nowitz M; Stanley J; Grant E; Huthwaite M; Dunn H
    CNS Drugs; 2017 Jan; 31(1):75-85. PubMed ID: 27826741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colonic transit time and IBS symptoms: what's the link?
    Törnblom H; Van Oudenhove L; Sadik R; Abrahamsson H; Tack J; Simrén M
    Am J Gastroenterol; 2012 May; 107(5):754-60. PubMed ID: 22334251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Linear discriminant analysis of symptoms in patients with chronic constipation: validation of a new scoring system (KESS).
    Knowles CH; Eccersley AJ; Scott SM; Walker SM; Reeves B; Lunniss PJ
    Dis Colon Rectum; 2000 Oct; 43(10):1419-26. PubMed ID: 11052520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
    Bouchoucha M; Devroede G; Bon C; Bejou B; Mary F; Benamouzig R
    Tech Coloproctol; 2017 Feb; 21(2):125-132. PubMed ID: 28066860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.